Article Versions Notes

Bossennec M, Rodriguez C, Hubert M, Di-Roio A, Machon C, Guitton J, Battiston-Montagne P, Couturier M, Marotte H, Caux C, et al. Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production. Journal of Clinical Medicine. 2019; 8(11):1859. https://doi.org/10.3390/jcm8111859

Bossennec, Marion, Céline Rodriguez, Margaux Hubert, Anthony Di-Roio, Christelle Machon, Jérôme Guitton, Priscilla Battiston-Montagne, Mathilde Couturier, Hubert Marotte, Christophe Caux, and et al. 2019. "Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production" Journal of Clinical Medicine 8, no. 11: 1859. https://doi.org/10.3390/jcm8111859

Bossennec, M., Rodriguez, C., Hubert, M., Di-Roio, A., Machon, C., Guitton, J., Battiston-Montagne, P., Couturier, M., Marotte, H., Caux, C., Coury, F., & Ménétrier-Caux, C. (2019). Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production. Journal of Clinical Medicine, 8(11), 1859. https://doi.org/10.3390/jcm8111859